Şirket hakkında

Xeno Biosciences, Inc. is a biotechnology company provider of novel class of treatments for metabolic diseases. Xeno Biosciences, Inc. operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.

US
Bilinmeyen
Bilinmeyen
Doğrulanmamış şirket